πŸ‡ΊπŸ‡Έ FDA
Patent

US 10316039

P2X3 and/or P2X2/3 compounds and methods

granted A61KA61K31/437A61K31/444

Quick answer

US patent 10316039 (P2X3 and/or P2X2/3 compounds and methods) held by Asana BioSciences, LLC expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/437, A61K31/444, A61K31/4545, A61K31/496